Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $3.1M | 1 | 98.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23,770 | 14 | 0.8% |
| Food and Beverage | $6,836 | 477 | 0.2% |
| Travel and Lodging | $2,387 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Skye Orthobiologics LLC | $3.1M | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $27,917 | 85 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $1,770 | 244 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $1,059 | 23 | $0 (2023) |
| ITI, Inc. | $552.34 | 33 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $257.90 | 15 | $0 (2020) |
| Allergan Inc. | $228.59 | 38 | $0 (2017) |
| Corium, LLC | $187.47 | 5 | $0 (2023) |
| Gilead Sciences, Inc. | $163.99 | 7 | $0 (2022) |
| Astellas Pharma US Inc | $154.30 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3.1M | 1 | Skye Orthobiologics LLC ($3.1M) |
| 2023 | $569.55 | 18 | ACADIA Pharmaceuticals Inc ($245.29) |
| 2022 | $914.79 | 36 | ACADIA Pharmaceuticals Inc ($468.77) |
| 2021 | $539.08 | 24 | ITI, Inc. ($228.12) |
| 2020 | $630.34 | 36 | ACADIA Pharmaceuticals Inc ($176.91) |
| 2019 | $5,376 | 100 | Janssen Pharmaceuticals, Inc ($4,469) |
| 2018 | $6,650 | 96 | Janssen Pharmaceuticals, Inc ($6,147) |
| 2017 | $18,313 | 184 | Janssen Pharmaceuticals, Inc ($17,301) |
All Payment Transactions
495 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/15/2024 | Skye Orthobiologics LLC | — | Debt forgiveness | Cash or cash equivalent | $3,082,225.00 | General |
| 12/06/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: CNS | ||||||
| 11/15/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: CNS | ||||||
| 10/27/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: CNS | ||||||
| 08/03/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Neurology | ||||||
| 06/07/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: BH | ||||||
| 05/31/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: PSYCHIATRY | ||||||
| 05/03/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PSYCHIATRY | ||||||
| 04/05/2023 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Diabetes | ||||||
| 03/29/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $84.72 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 03/29/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $38.52 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/29/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/29/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROLOGY | ||||||
| 03/10/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.20 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/08/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 01/26/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $122.59 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/25/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/21/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.89 | General |
| 10/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2022 | Corium, LLC | ADLARITY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 10/01/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $99.68 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,601 | 13,967 | $5.5M | $4.0M |
| 2022 | 37 | 9,291 | 22,618 | $2.9M | $1.6M |
| 2021 | 15 | 5,469 | 15,376 | $1.4M | $1.0M |
| 2020 | 14 | 5,956 | 15,205 | $1.4M | $1.0M |
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| Q4217 | Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter | Office | 2023 | 20 | 2,796 | $4.2M | $3.2M | 77.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 1,165 | 4,366 | $423,074 | $287,678 | 68.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 406 | 2,060 | $193,398 | $140,595 | 72.7% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 476 | 1,390 | $185,410 | $114,855 | 61.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 207 | 207 | $142,830 | $56,706 | 39.7% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 207 | 207 | $97,497 | $42,201 | 43.3% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 140 | 380 | $15,903 | $10,989 | 69.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 84 | 85 | $23,331 | $10,698 | 45.9% |
| 15271 | Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | Office | 2023 | 19 | 89 | $39,160 | $10,056 | 25.7% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 194 | 196 | $39,200 | $10,055 | 25.7% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 279 | 500 | $15,255 | $9,473 | 62.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 83 | 84 | $13,447 | $7,306 | 54.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 244 | 265 | $17,490 | $6,440 | 36.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 100 | 101 | $8,953 | $6,322 | 70.6% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 149 | 195 | $9,512 | $5,758 | 60.5% |
| 99345 | Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes | Office | 2023 | 31 | 31 | $7,218 | $4,306 | 59.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 53 | 152 | $22,950 | $3,988 | 17.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 78 | 84 | $4,574 | $3,127 | 68.4% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 74 | $11,100 | $3,108 | 28.0% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 23 | 23 | $3,946 | $2,959 | 75.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 30 | 30 | $4,009 | $2,797 | 69.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 35 | 49 | $6,337 | $2,749 | 43.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 54 | 88 | $13,200 | $2,719 | 20.6% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 69 | $10,350 | $2,323 | 22.4% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 207 | 207 | $4,968 | $1,978 | 39.8% |
About Dr. Alexander Frank, M.D
Dr. Alexander Frank, M.D is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164450573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Frank, M.D has received a total of $3.1M in payments from pharmaceutical and medical device companies, with $3.1M received in 2024. These payments were reported across 495 transactions from 27 companies. The most common payment nature is "Debt forgiveness" ($3.1M).
As a Medicare-enrolled provider, Frank has provided services to 25,317 Medicare beneficiaries, totaling 67,166 services with total Medicare billing of $7.6M. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Oklahoma City, OK
- Active Since 06/28/2006
- Last Updated 10/22/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164450573
Products in Payments
- XARELTO (Drug) $27,850
- NUEDEXTA (Drug) $1,753
- NUPLAZID (Drug) $1,059
- CAPLYTA (Drug) $552.34
- ENTRESTO (Drug) $257.90
- NAMZARIC (Drug) $143.19
- MYRBETRIQ (Drug) $132.12
- DRIZALMA SPRINKLE (Drug) $110.34
- Adlarity (Drug) $102.50
- AUSTEDO (Drug) $91.95
- LINZESS (Drug) $85.40
- Azstarys (Drug) $68.42
- LONHALA MAGNAIR (Drug) $65.03
- COLLAGENASE SANTYL (Drug) $52.14
- INVEGA SUSTENNA (Drug) $43.33
- TRELEGY ELLIPTA (Drug) $36.16
- PERSERIS (Drug) $35.33
- APTIOM (Drug) $32.25
- Nuedexta (Drug) $31.02
- Nayzilam (Drug) $24.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Dr. Corey Finch, Md, MD
Emergency Medicine — Payments: $5,461